issue contents
August 2023 issue

Cover illustration: Crystal structure of PvS1Cat-Tryps (depicted as a green surface) in complex with the inhibitor MAM-117 (yellow) [Martinez et al. (2023), Acta Cryst. D79, 721–734]. The emergence of multi-resistant Plasmodium sp. parasites requires the identification of new antimalarials. Subtilisin-like protease 1 (SUB1) belongs to a new generation of drug targets because it plays a crucial role during egress of the parasite from infected host cells at different stages of its life cycle. The high-resolution structure of Plasmodium vivax SUB1, produced under controlled conditions and complexed with a substrate-derived pseudo-peptide inhibitor, is shown here.
letters to the editor
accessCCP4
access
accessresearch papers
access
accessModule walking using an SH3-like cell-wall-binding domain leads to a new GH184 family of muramidases
access
journal menu







